These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 535177)

  • 1. Delusions of infestation: treatment by depot injections of neuroleptics.
    Frithz A
    Clin Exp Dermatol; 1979 Dec; 4(4):485-8. PubMed ID: 535177
    [No Abstract]   [Full Text] [Related]  

  • 2. Depot injections for affective disorders.
    Naylor GJ; Scott CR
    Br J Psychiatry; 1980 Jan; 136():105. PubMed ID: 7357213
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
    Carney MW; Sheffield BF
    Br J Psychiatry; 1976 Nov; 129():476-81. PubMed ID: 990663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience with depot neuroleptics].
    Arató M; Erdós A
    Orv Hetil; 1979 Apr; 120(17):1015-21. PubMed ID: 372888
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with depot neuroleptics].
    Peterová E; Baudis P; Dvoráková M; Vencovský E
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():173-6. PubMed ID: 829618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depot neuroleptics in a community mental health service.
    Blake B
    Br Med J; 1979 Jul; 2(6181):48-9. PubMed ID: 466266
    [No Abstract]   [Full Text] [Related]  

  • 7. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot injections and tardive dyskinesia.
    Gibson AC
    Br J Psychiatry; 1978 Oct; 133():361-5. PubMed ID: 709010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R; Bannerjee A; Ghosh N
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
    Eufe R; Wegener G
    Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
    [No Abstract]   [Full Text] [Related]  

  • 11. A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
    Wistedt B; Jørgensen A; Wiles D
    Psychopharmacology (Berl); 1982; 78(4):301-4. PubMed ID: 6818587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial.
    Chowdhury ME; Chacon C
    Compr Psychiatry; 1980; 21(2):135-9. PubMed ID: 6991205
    [No Abstract]   [Full Text] [Related]  

  • 13. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
    Dencker SJ; Lepp M; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():10-28. PubMed ID: 6931470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J; Villiger J; Hunter L
    Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the effects of fluphenazine-depot and flupenthixol-depot in the treatment of schizophrenic psychoses].
    Bilikiewicz A; Sep-Kowalikowa B
    Psychiatr Pol; 1976; 10(4):359-66. PubMed ID: 981411
    [No Abstract]   [Full Text] [Related]  

  • 16. Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.
    Johnson DA
    Br J Psychiatry; 1979 Dec; 135():524-30. PubMed ID: 534806
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
    Lipska B; Szukalski B; Nurowska K; Welbel L
    Psychiatr Pol; 1986; 20(1):1-7. PubMed ID: 3725983
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Choreiform movements after depot injections of flupenthixol.
    Carney MW
    Br J Psychiatry; 1974 Dec; 125():609. PubMed ID: 4457212
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum concentration of depot neuroleptics in tardive dyskinesia.
    Fairbairn AF; Rowell FJ; Hui SM; Hassanyeh F; Robinson AJ; Eccleston D
    Br J Psychiatry; 1983 Jun; 142():579-83. PubMed ID: 6882980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
    Dencker SJ; Frankenberg K; Hansen V; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():29-40. PubMed ID: 6931471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.